Suppr超能文献

外视镜显微手术:脑肿瘤手术的范式转变?与标准手术显微镜的比较。

Exoscopic Microsurgery: A Change of Paradigm in Brain Tumor Surgery? Comparison with Standard Operative Microscope.

作者信息

Di Cristofori Andrea, Graziano Francesca, Rui Chiara Benedetta, Rebora Paola, Di Caro Diego, Chiarello Gaia, Stefanoni Giovanni, Julita Chiara, Florio Santa, Ferlito Davide, Basso Gianpaolo, Citerio Giuseppe, Remida Paolo, Carrabba Giorgio, Giussani Carlo

机构信息

Department of Medicine and Surgery, University of Milano-Bicocca, Ospedale San Gerardo, Piazza Ateneo Nuovo, 120126 Milan, Italy.

Neurosurgery, Fondazione IRCCS San Gerardo dei Tintori Via G.B. Pergolesi 33, 20900 Monza, Italy.

出版信息

Brain Sci. 2023 Jul 6;13(7):1035. doi: 10.3390/brainsci13071035.

Abstract

BACKGROUND

The exoscope is a high-definition telescope recently introduced in neurosurgery. In the past few years, several reports have described the advantages and disadvantages of such technology. No studies have compared results of surgery with standard microscope and exoscope in patients with glioblastoma multiforme (GBM).

METHODS

Our retrospective study encompassed 177 patients operated on for GBM (WHO 2021) between February 2017 and August 2022. A total of 144 patients were operated on with a microscope only and the others with a 3D4K exoscope only. All clinical and radiological data were collected. Progression-free survival (PFS) and overall survival (OS) have been estimated in the two groups and compared by the Cox model adjusting for potential confounders (e.g., sex, age, Karnofsky performance status, gross total resection, MGMT methylated promoter, and operator's experience).

RESULTS

IDH was mutated in 9 (5.2%) patients and MGMT was methylated in 76 (44.4%). Overall, 122 patients received a gross total resection, 14 patients received a subtotal resection, and 41 patients received a partial resection. During follow-up, 139 (73.5%) patients experienced tumor recurrence and 18.7% of them received a second surgery. After truncation to 12 months, the median PFS for patients operated on with the microscope was 8.82 months, while for patients operated on with the exoscope it was >12 months. Instead, the OS was comparable in the two groups. The multivariable Cox model showed that the use of microscope compared to the exoscope was associated with lower progression-free survival (hazard ratio = 3.55, 95%CI = 1.66-7.56, = 0.001).

CONCLUSIONS

The exoscope has proven efficacy in terms of surgical resection, which was not different to that of the microscope. Furthermore, patients operated on with the exoscope had a longer PFS. A comparable OS was observed between microscope and exoscope, but further prospective studies with longer follow-up are needed.

摘要

背景

外视镜是神经外科领域最近引入的一种高清望远镜。在过去几年里,有几份报告描述了这种技术的优缺点。尚无研究比较多形性胶质母细胞瘤(GBM)患者使用标准显微镜和外视镜进行手术的结果。

方法

我们的回顾性研究纳入了2017年2月至2022年8月期间接受GBM(世界卫生组织2021年)手术的177例患者。其中144例患者仅使用显微镜进行手术,其余患者仅使用3D4K外视镜进行手术。收集了所有临床和放射学数据。对两组患者的无进展生存期(PFS)和总生存期(OS)进行了评估,并通过Cox模型进行比较,同时对潜在混杂因素(如性别、年龄、卡氏功能状态、全切除、MGMT甲基化启动子和术者经验)进行了调整。

结果

9例(5.2%)患者存在异柠檬酸脱氢酶(IDH)突变,76例(44.4%)患者MGMT甲基化。总体而言,122例患者接受了全切除,14例患者接受了次全切除,41例患者接受了部分切除。在随访期间,139例(73.5%)患者出现肿瘤复发,其中18.7%的患者接受了二次手术。截尾至12个月后,使用显微镜手术的患者中位PFS为8.82个月,而使用外视镜手术的患者中位PFS大于12个月。相反,两组患者的OS相当。多变量Cox模型显示,与外视镜相比,使用显微镜与较低的无进展生存期相关(风险比=3.55,95%置信区间=1.66-7.56,P=0.001)。

结论

外视镜在手术切除方面已被证明有效,与显微镜相当。此外,使用外视镜手术的患者PFS更长。显微镜和外视镜组的OS相当,但需要进行随访时间更长的进一步前瞻性研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d830/10377370/1db032402ac8/brainsci-13-01035-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验